Cite
HARVARD Citation
Nelson, A. et al. (2021). Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction. Circulation. 144 (1), pp. 74-84. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nelson, A. et al. (2021). Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction. Circulation. 144 (1), pp. 74-84. [Online].